[Federal Register Volume 89, Number 111 (Friday, June 7, 2024)]
[Proposed Rules]
[Page 48515]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-12504]


 ========================================================================
 Proposed Rules
                                                 Federal Register
 ________________________________________________________________________
 
 This section of the FEDERAL REGISTER contains notices to the public of 
 the proposed issuance of rules and regulations. The purpose of these 
 notices is to give interested persons an opportunity to participate in 
 the rule making prior to the adoption of the final rules.
 
 ========================================================================
 

  Federal Register / Vol. 89, No. 111 / Friday, June 7, 2024 / Proposed 
Rules  

[[Page 48515]]



DEPARTMENT OF JUSTICE

Drug Enforcement Administration

21 CFR Part 1308

[Docket No. DEA-1156]


Announcement of Stayed Hearing: Schedules of Controlled 
Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-
dimethoxy-4-chloroamphetamine (DOC) in Schedule I

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: Notification of stay of hearing on proposed rulemaking.

-----------------------------------------------------------------------

SUMMARY: This is a notification that the Drug Enforcement 
Administration has stayed the June 10, 2024 hearing on the proposed 
placement of two phenethylamine hallucinogens, as identified in the 
proposed rule, in schedule I of the Controlled Substances Act.

DATES: The hearing will not be taking place on June 10, 2024.

ADDRESSES: Office of the Administrative Law Judges, 8701 Morrissette 
Drive, Springfield, Virginia 22152.

FOR FURTHER INFORMATION CONTACT: Hearing Clerk, Debralynn Rosario, 
Office of the Administrative Law Judges, 8701 Morrissette Drive, 
Springfield, Virginia 22152; Telephone: (571) 362-7035.

SUPPLEMENTARY INFORMATION: 

Background

    On December 13, 2023, the Drug Enforcement Administration (DEA) 
published a Notice of Proposed Rulemaking (NPRM) in the Federal 
Register (88 FR 86278) to place two phenethylamine hallucinogen 
substances in schedule I of the Controlled Substances Act (CSA) (21 
U.S.C. 801, et seq.). Specifically, in this NPRM, DEA proposed to 
schedule the following two controlled substances in schedule I of the 
CSA, including their salts, isomers, and salts of isomers whenever the 
existence of such salts, isomers, and salts of isomers is possible 
within the specific chemical designation:
     2,5-dimethoxy-4-iodoamphetamine (DOI), and
     2,5-dimethoxy-4-chloroamphetamine (DOC).
    On April 9, 2024, DEA published a Notice of Hearing on Proposed 
Rulemaking (Notice of Hearing) in the FR (89 FR 24750) stating that a 
hearing would commence on June 10, 2024. Subsequently, a collateral 
matter was filed in a U.S. District Court and the DEA Administrative 
Law Judge stayed the administrative hearing proceedings pending a 
decision from the U.S. District Court. As the matter before DEA is 
currently stayed, no hearing will commence on June 10, 2024.

Signing Authority

    This document of the Drug Enforcement Administration was signed on 
June 3, 2024, by Administrator Anne Milgram. That document with the 
original signature and date is maintained by DEA. For administrative 
purposes only, and in compliance with requirements of the Office of the 
Federal Register, the undersigned DEA Federal Register Liaison Officer 
has been authorized to sign and submit the document in electronic 
format for publication, as an official document of DEA. This 
administrative process in no way alters the legal effect of this 
document upon publication in the Federal Register.

Heather Achbach,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2024-12504 Filed 6-6-24; 8:45 am]
BILLING CODE 4410-09-P